Business Context and Reporting Period
This Form 8-K filing by Integrity Applications, Inc. (not Glucotrack, Inc., as noted in the metadata) reports a material definitive agreement entered into on August 29, 2014. The report was filed on September 5, 2014. The Company, a Delaware corporation based in Ashkelon, Israel, executed a Securities Purchase Agreement with accredited investors to raise capital through the issuance of preferred stock and warrants.
Key Financial Metrics and Transaction Details
- Gross Proceeds: $3,036,000 raised from the sale of 3,036 Units.
- Instrument Structure: Each Unit consists of one share of Series B 5.5% Convertible Preferred Stock (stated value $1,000), a Series B-1 Warrant (exercise price $5.80), and a Series B-2 Warrant (exercise price $10.00).
- Conversion Potential: The Preferred Stock is convertible into an aggregate of 523,449 shares of Common Stock at an initial price of $5.80 per share.
- Warrant Potential: The Warrants are exercisable for an aggregate of 1,046,898 shares of Common Stock.
- Dividend Rate: Cumulative dividends of 5.5% per annum on the stated value, payable quarterly starting September 30, 2014.
- Placement Agent Compensation: The Company paid a total of 13% of the aggregate sales price in cash (7% commission, 3% management fee, 3% expense allowance) plus issued warrants to purchase 157,035 shares of Common Stock.
Material Changes and Adjustments
The filing details a significant capital raise and a corresponding adjustment to existing securities. As a result of this issuance, the exercise price of the Company's outstanding Series A Warrants was adjusted downward from $6.96 per share to $5.80 per share. The number of shares issuable upon exercise of the Series A Warrants increased to maintain the aggregate exercise price. Additionally, the Company amended its Certificate of Incorporation to designate the rights and preferences of the new Series B Preferred Stock.
Guidance, Risks, and Contingencies
- Redemption Triggers: The Company may be obligated to redeem the Preferred Stock in cash upon material breach of contract, change in control, insolvency events, or delisting of Common Stock.
- Forced Conversion: The Company may force conversion if the Common Stock trades above $10.00 for 20 of 30 consecutive trading days with sufficient volume, or upon approval for listing on a national securities exchange.
- Registration Rights: The Company must file a registration statement within 90 days for the resale of Conversion Shares and Warrant Shares. Failure to do so incurs partial liquidated damages of 2% of the purchase price.
- Restrictions: The Company is restricted from incurring new indebtedness, repurchasing junior securities, or entering into affiliate transactions without the consent of Preferred Stockholders as long as 35% of the Series B stock is outstanding.
- Buy-In Protection: The Company faces cash penalties and liquidated damages ($10 per trading day per $1,000 stated value) if it fails to timely deliver shares upon conversion, forcing a holder to "buy-in" shares in the market.
Investor Verification Checklist
- Verify the current cash position and ability to fund the 5.5% quarterly dividend payments, particularly given the requirement to pay in cash if Series A obligations are satisfied.
- Confirm the status of the registration statement filing required within 90 days of issuance to avoid 2% liquidated damages.
- Assess the dilution impact of the 1,046,898 warrant shares and 523,449 conversion shares relative to the current outstanding Common Stock.
- Review the terms of the Series A Preferred Stock to understand the interaction of dividend payments and redemption obligations between Series A and Series B.
- Monitor the Common Stock trading price relative to the $10.00 forced conversion threshold and the $5.80 conversion price.